This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Emergent BioSolutions Inc
EBS : NYSE : Health Care
$26.98 -0.13 | -0.48%
Today's Range: 26.57 - 27.64
Avg. Daily Volume: 201,800
12/18/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
EBS EMERGENT BIOSOLUTIONS INC 26.37 990.25 54.94 400.27 29.43
NLNK NEWLINK GENETICS CORP 35.42 990.34 n/m 3.64 231.60
SGMO SANGAMO BIOSCIENCES INC 14.07 962.44 n/m 37.79 44.24
ARNA ARENA PHARMACEUTICALS INC 4.09 900.27 n/m 34.30 -55.36
INFI INFINITY PHARMACEUTICALS INC 17.99 877.32 n/m 160.64 n/a
ENTA ENANTA PHARMACEUTICALS INC 46.43 862.81 26.38 47.74 1038.31
IMGN IMMUNOGEN INC 10.01 860.22 n/m 55.88 14.83
LGND LIGAND PHARMACEUTICAL INC 53.89 1071.66 168.41 56.28 17.55
GHDX GENOMIC HEALTH INC 32.66 1036.04 n/m 275.40 8.76
AMAG AMAG PHARMACEUTICALS INC 40.83 1033.20 n/m 92.84 15.63
HALO HALOZYME THERAPEUTICS INC 8.15 1021.90 n/m 57.46 -10.36
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

EBS Ind Avg S&P 500
54.94 66.62 19.74

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs